OPKO Health, Inc. Sales Revenue, Goods, Net (Deprecated 2018-01-31)
OPKO Health, Inc. (OPK) reported Sales Revenue, Goods, Net (Deprecated 2018-01-31) of $27.85 million for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-08.
Discontinued › Expense Statement › Operating Expenses
us-gaap:SalesRevenueGoodsNet · last filed 2019-01-29
- OPKO Health, Inc. sales revenue, goods, net (deprecated 2018-01-31) for the quarter ending 2018-03-31 was $27.85M, a 25.28% increase year-over-year.
- OPKO Health, Inc. sales revenue, goods, net (deprecated 2018-01-31) for the quarter ending 2017-12-31 was $33.77M, a 67.23% increase year-over-year.
- OPKO Health, Inc. sales revenue, goods, net (deprecated 2018-01-31) for the quarter ending 2017-09-30 was $22.80M, a 10.82% increase year-over-year.
- OPKO Health, Inc. sales revenue, goods, net (deprecated 2018-01-31) for the quarter ending 2017-06-30 was $28.97M, a 27.00% increase year-over-year.
- OPKO Health, Inc. sales revenue, goods, net (deprecated 2018-01-31) for fiscal 2014 was $76.98M, a 12.94% increase from fiscal 2013.
- OPKO Health, Inc. sales revenue, goods, net (deprecated 2018-01-31) for fiscal 2013 was $68.16M, a 50.48% increase from fiscal 2012.
- OPKO Health, Inc. sales revenue, goods, net (deprecated 2018-01-31) for fiscal 2012 was $45.30M, a 62.67% increase from fiscal 2011.
- OPKO Health, Inc. sales revenue, goods, net (deprecated 2018-01-31) for fiscal 2011 was $27.84M, a 27.94% increase from fiscal 2010.
| Period end | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 3 month | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 3 month as first filed | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 6 month | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 6 month as first filed | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 9 month | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|---|---|
| 2018-03-31 | $27.85M 10-Q · filed 2018-05-08 | $61.62M derived: sum of 2 quarters · filed 2019-01-29 | $84.41M derived: sum of 3 quarters · filed 2019-01-29 | $113.38M derived: sum of 4 quarters · filed 2019-01-29 | ||
| 2017-12-31 | $33.77M derived: 8-K 12 month − 10-Q 9 month · filed 2019-01-29 | $56.56M derived: sum of 2 quarters · filed 2019-01-29 | $85.53M derived: sum of 3 quarters · filed 2019-01-29 | $107.76M 8-K · filed 2019-01-29 | ||
| 2017-09-30 | $22.80M 10-Q · filed 2017-11-08 | $51.76M derived: sum of 2 quarters · filed 2017-11-08 | $73.99M 10-Q · filed 2017-11-08 | $94.18M derived: sum of 4 quarters · filed 2019-01-29 | ||
| 2017-06-30 | $28.97M 10-Q · filed 2017-08-08 | $51.20M 10-Q · filed 2017-08-08 | $71.39M derived: sum of 3 quarters · filed 2019-01-29 | $91.96M derived: sum of 4 quarters · filed 2019-01-29 | ||
| 2017-03-31 | $22.23M 10-Q · filed 2018-05-08 | $42.42M derived: sum of 2 quarters · filed 2019-01-29 | $62.99M derived: sum of 3 quarters · filed 2019-01-29 | $85.80M derived: sum of 4 quarters · filed 2019-01-29 | ||
| 2016-12-31 | $20.19M derived: 8-K 12 month − 10-Q 9 month · filed 2019-01-29 | $40.76M derived: sum of 2 quarters · filed 2019-01-29 | $63.57M derived: sum of 3 quarters · filed 2019-01-29 | $83.47M 8-K · filed 2019-01-29 | ||
| 2016-09-30 | $20.57M 10-Q · filed 2017-11-08 | $43.38M derived: sum of 2 quarters · filed 2017-11-08 | $63.27M 10-Q · filed 2017-11-08 | $84.36M derived: sum of 4 quarters · filed 2019-01-29 | ||
| 2016-06-30 | $22.81M 10-Q · filed 2017-08-08 | $42.71M 10-Q · filed 2017-08-08 | $63.79M derived: sum of 3 quarters · filed 2019-01-29 | $84.55M derived: sum of 4 quarters · filed 2019-01-29 | ||
| 2016-03-31 | $19.90M 10-Q · filed 2017-05-10 | $40.98M derived: sum of 2 quarters · filed 2019-01-29 | $61.74M derived: sum of 3 quarters · filed 2019-01-29 | $84.59M derived: sum of 4 quarters · filed 2019-01-29 | ||
| 2015-12-31 | $21.08M derived: 8-K 12 month − 10-Q 9 month · filed 2019-01-29 | $41.84M derived: sum of 2 quarters · filed 2019-01-29 | $64.69M derived: sum of 3 quarters · filed 2019-01-29 | $80.15M 8-K · filed 2019-01-29 | ||
| 2015-09-30 | $20.77M 10-Q · filed 2016-11-07 | $43.61M derived: sum of 2 quarters · filed 2016-11-07 | $59.07M 10-Q · filed 2016-11-07 | $77.57M derived: sum of 4 quarters · filed 2017-03-01 | ||
| 2015-06-30 | $22.85M 10-Q · filed 2016-08-08 | $38.33M 10-Q · filed 2016-08-08 | $56.81M derived: sum of 3 quarters · filed 2017-03-01 | $74.10M derived: sum of 4 quarters · filed 2017-03-01 | ||
| 2015-03-31 | $15.49M 10-Q · filed 2016-05-09 | $33.96M derived: sum of 2 quarters · filed 2017-03-01 | $51.25M derived: sum of 3 quarters · filed 2017-03-01 | $72.64M derived: sum of 4 quarters · filed 2017-03-01 | ||
| 2014-12-31 | $18.47M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $35.76M derived: sum of 2 quarters · filed 2017-03-01 | $57.16M derived: sum of 3 quarters · filed 2017-03-01 | $76.98M 10-K · filed 2017-03-01 | ||
| 2014-09-30 | $17.29M 10-Q · filed 2015-11-09 | $38.68M derived: sum of 2 quarters · filed 2015-11-09 | $58.51M 10-Q · filed 2015-11-09 | $75.96M derived: sum of 4 quarters · filed 2016-02-29 | ||
| 2014-06-30 | $21.39M 10-Q · filed 2015-08-05 | $41.22M 10-Q · filed 2015-08-05 | $58.67M derived: sum of 3 quarters · filed 2016-02-29 | $75.24M derived: sum of 4 quarters · filed 2016-02-29 | ||
| 2014-03-31 | $19.83M 10-Q · filed 2015-05-11 | $37.28M derived: sum of 2 quarters · filed 2016-02-29 | $53.84M derived: sum of 3 quarters · filed 2016-02-29 | $72.46M derived: sum of 4 quarters · filed 2016-02-29 | ||
| 2013-12-31 | $17.45M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $34.02M derived: sum of 2 quarters · filed 2016-02-29 | $52.63M derived: sum of 3 quarters · filed 2016-02-29 | $68.16M 10-K · filed 2016-02-29 | ||
| 2013-09-30 | $16.56M 10-Q · filed 2014-11-07 | $35.18M derived: sum of 2 quarters · filed 2014-11-07 | $50.71M 10-Q · filed 2014-11-07 | $65.95M derived: sum of 4 quarters · filed 2015-02-27 | ||
| 2013-06-30 | $18.62M 10-Q · filed 2014-08-11 | $34.15M 10-Q · filed 2014-08-11 | $49.39M derived: sum of 3 quarters · filed 2015-02-27 | $60.88M derived: sum of 4 quarters · filed 2015-02-27 | ||
| 2013-03-31 | $15.53M 10-Q · filed 2014-05-09 | $30.77M derived: sum of 2 quarters · filed 2015-02-27 | $42.27M derived: sum of 3 quarters · filed 2015-02-27 | $52.18M derived: sum of 4 quarters · filed 2015-02-27 | ||
| 2012-12-31 | $15.24M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | $26.74M derived: sum of 2 quarters · filed 2015-02-27 | $36.66M derived: sum of 3 quarters · filed 2015-02-27 | $45.30M 10-K · filed 2015-02-27 | ||
| 2012-09-30 | $11.49M 10-Q · filed 2013-11-12 | $21.41M derived: sum of 2 quarters · filed 2013-11-12 | $30.05M 10-Q · filed 2013-11-12 | $35.78M derived: sum of 4 quarters · filed 2014-03-03 | ||
| 2012-06-30 | $9.92M 10-Q · filed 2013-08-09 | $18.56M 10-Q · filed 2013-08-09 | $24.29M derived: sum of 3 quarters · filed 2014-03-03 | $31.05M derived: sum of 4 quarters · filed 2014-03-03 | ||
| 2012-03-31 | $8.64M 10-Q · filed 2013-05-10 | $14.37M derived: sum of 2 quarters · filed 2014-03-03 | $21.13M derived: sum of 3 quarters · filed 2014-03-03 | $29.56M derived: sum of 4 quarters · filed 2014-03-03 | ||
| 2011-12-31 | $5.73M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-03 | $12.49M derived: sum of 2 quarters · filed 2014-03-03 | $20.92M derived: sum of 3 quarters · filed 2014-03-03 | $27.84M 10-K · filed 2014-03-03 | ||
| 2011-09-30 | $6.76M 10-Q · filed 2012-11-09 | $15.19M derived: sum of 2 quarters · filed 2012-08-09 | $22.11M 10-Q · filed 2012-11-09 | $27.64M derived: sum of 4 quarters · filed 2013-03-18 | ||
| 2011-06-30 | $8.43M 10-Q · filed 2012-08-09 | $10.13M 10-Q · filed 2011-08-08 | $15.38M 10-Q · filed 2012-08-09 | $18.77M 10-Q · filed 2011-08-08 | $20.88M derived: sum of 3 quarters · filed 2013-03-18 | $26.56M derived: sum of 4 quarters · filed 2013-03-18 |
| 2011-03-31 | $6.95M 10-Q · filed 2012-05-10 | $12.45M derived: sum of 2 quarters · filed 2013-03-18 | $18.13M derived: sum of 3 quarters · filed 2013-03-18 | $25.58M derived: sum of 4 quarters · filed 2013-03-18 | ||
| 2010-12-31 | $5.50M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | $11.18M derived: sum of 2 quarters · filed 2013-03-18 | $18.63M derived: sum of 3 quarters · filed 2013-03-18 | $21.76M 10-K · filed 2013-03-18 | ||
| 2010-09-30 | $5.68M 10-Q · filed 2011-11-09 | $13.13M derived: sum of 2 quarters · filed 2011-11-09 | $16.26M 10-Q · filed 2011-11-09 | |||
| 2010-06-30 | $7.46M 10-Q · filed 2011-08-08 | $15.38M 10-Q · filed 2011-08-08 | ||||
| 2009-12-31 | $4.42M 10-K · filed 2012-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |